Microflora Changes With the Use of a Vaginal Microbicide
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 29 (5), 288-293
- https://doi.org/10.1097/00007435-200205000-00007
Abstract
The rate of HIV transmission is increasing more in women than in any other group. There is an urgent need for the development of microbicides with activity against this virus that women can use during intercourse. These products must be convenient, effective, and safe, and ideally they will cause minimal disruption in the normal vaginal ecosystem. The objective of this study was to evaluate changes in vaginal microflora, specifically Lactobacillus species, with the use of BufferGel. A prospective cohort study was performed to evaluate the change in vaginal flora before and after BufferGel use. BufferGel was applied vaginally once or twice daily for 14 days by low-risk abstinent and monogamous women. There was no change in frequency of Lactobacillus species after BufferGel use. However, there was a decrease in H2O2-producing lactobacilli (from 4.9 × 107 to 1.1 × 107 cfu;P = 0.001). The proportion of facultative gram-negative rods present increased from 27% to 65% after BufferGel use, whereas obligately anaerobic microbes decreased from 62% to 38%. Use of BufferGel once or twice daily for 14 days resulted in no clinically significant change in Lactobacillus colonization.Keywords
This publication has 27 references indexed in Scilit:
- Safety and Tolerability of BufferGel, a Novel Vaginal Microbicide, in Women in the United StatesClinical Infectious Diseases, 2001
- The Effects of Three Nonoxynol‐9 Preparations on Vaginal Flora and EpitheliumThe Journal of Infectious Diseases, 1999
- Design of a “Microbicide” for Prevention of Sexually Transmitted Diseases Using “Inactive” Pharmaceutical ExcipientsBiologicals, 1999
- Response of gonococcal clinical isolates to acidic conditionsJournal of Medical Microbiology, 1999
- Increased Cerebrospinal Fluid Ganglioside GD3 Concentrations as a Marker of Microglial Activation in HIV Type 1 InfectionAIDS Research and Human Retroviruses, 1998
- AIDS in women in the United States. Recent trendsJAMA, 1997
- Challenges for the development of female-controlled vaginal microbicidesAIDS, 1994
- Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutesJAMA, 1992
- Effects of Chlorhexidine Gluconate Douche on Normal Vaginal FloraGynecologic and Obstetric Investigation, 1992
- INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITROThe Lancet, 1985